Ascendis Pharma AS (ASND)

Ascendis Pharma AS (ASND) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $16B; returns 1 day +0.2%, 1 week +8.0%, 1 year +21.1%.

Ascendis Pharma A/S is a global biopharmaceutical company based in Denmark, focused on developing innovative therapies for rare diseases using its proprietary TransCon (Transient Conjugation) technology platform.

Groups ASND belongs to

• Biopharmaceutical
• Biotechnology
• Rare Diseases
• Healthcare
• Commercial Stage Biotech
• Life Sciences
• Endocrinology
• Long-Acting Injectables
• Pharmaceuticals
• Drug Discovery
• Metabolic Disorders

ASND financial model: income statement, cash flow and balance sheet